Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

Conditions:   Stage I Uterine Sarcoma;   Uterine LeiomyosarcomaInterventions:   Drug: doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Drug: docetaxel;   Biological: filgrastim;   Biological: pegfilgrastim;   Other: clinical observationSponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)Recruiting - verified March 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials